Anika Therapeutics’ CEO dies unexpectedly, board looks for immediate replacement

Joseph Darling, president and CEO of Anika Therapeutics, died Jan. 29. He was 62 years old.

Advertisement

Anika’s board of directors is beginning an immediate search for a new CEO.

In the meantime, an office of the president has been established to provide leadership and oversight of day-to-day operations.

Sylvia Cheung, CFO, James Loerop, executive vice president of business development and strategic planning, and Thomas Finnerty, executive vice president of human resources, will occupy the temporary office of the president.

Mr. Darling joined Anika as president in 2017 and was appointed CEO in 2018.

He had more than 21 years of experience in executive management and leadership roles, according to his LinkedIn profile, including positions at Smith+Nephew, Arthrosurface, Baxter Healthcare and Conmed.

More articles on devices:
Breaking down the 3 major robots in spine surgery
Johnson & Johnson sets sights on robotics in 2020 in orthopedics and beyond
Moody’s predicts rapid growth for robotic orthopedic surgery—key insights on Stryker, Zimmer Biomet  

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.